Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of vandetanib when given
together with radiation therapy in treating young patients with newly diagnosed diffuse brain
stem glioma.